The research in this book is focused on the application of the concept of polymer-drug conjugation to prepare conjugates. These conjugates acts as pro-drugs from which bioactive agents are released to predestined biological environment. The macromolecular carriers used are biodegradable, non-toxic, easily conveyed to the target cells or tissues, with different solubilizing groups to ensure rapid dissipation of the conjugate in the central circulation system. The polymer-drug connective link is to provide delayed and controlled drug release thereby ensuring restriction of drug serum concentration and reduction of organ toxicity. This book elaborates on the conjugation of 4- and 8-aminoquinolines to polymers to overcome the drug resistance associated with the currently used aminoquinolines. Presently, some antimalarial drugs have been found to be anti-carcinogenic and have ability to inhibit tumor development and as such, this book is also focused on the co-conjugation of an anticancer and an antimalarial agent on a single carrier, whereby the antimalarial is expected to serve as potentiating and resistance reducing agent.

Blessing Aderibigbe graduated from the University of the Witwatersrand, South Africa, where she completed her PhD research in the application of the concept of Polymer-drug conjugation for cancer chemotherapy. She is presently a Postdoctoral fellow at the University of Johannesburg, South Africa.